A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure

Status:	Completed
Conditions:	Other Indications, Skin and Soft Tissue Infections
Therapuetic Areas:	Dermatology / Plastic Surgery, Other
Healthy:	No
Age Range:	35 - 65
Updated:	10/19/2013
Start Date:	January 2013
End Date:	March 2014
Contact:	Pfizer CT.gov Call Center
Phone:	1-800-718-1021

Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin

The study hypothesis is that Imedeen will show effects on skin health, when compared to
placebo over a 6 month intervention period with respect to changes in skin appearance, skin
density, moisture, and in fine lines and wrinkles.

Inclusion Criteria:

In general good health and have no contraindications to the study product; Have
Fitzpatrick Skin Type I-IV as determined by a trained evaluator. Have Glogau
Classification of Photoaging of II or III as determined by the investigator.

Exclusion Criteria:

Use of any dietary supplement, over-the-counter or prescription product with the
indication of improving the appearance or condition of the skin within one month of
baseline.

History of or current disease or condition of the skin that the investigator deems
inappropriate for participation (eg, atopic skin, facial scars, psoriasis, eczema, other
scaly inflammatory diseases).

Subjects who have had a facial cosmetic procedures (eg, fillers, toxins, facial peel) or
invasive surgical procedures (eg, laser treatment or face lift) or other facial treatments
by a physician or skin care professional within the last 6 to 9 months from baseline
(pending procedure type) or plan to have a treatment during the study.

We found this trial at

sites

Pfizer Investigational Site

Atlantis, Florida 33462

from

Atlantis, FL